ARCA Biotechnology Index (BTK) Companies by Market Cap
The ARCA Biotechnology Index (BTK) tracks 30 constituent companies with a combined market cap of $945.15 Billion, covering the largest publicly traded companies in USA. This ranking lists all BTK index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$945.15 Billion
Constituent Companies
30
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 1 |
Amgen Inc
NASDAQ:AMGN |
% | $195.87 Billion | Healthcare | Drug Manufacturers - General | $363.39 | -0.06% |
| 2 |
Gilead Sciences Inc
NASDAQ:GILD |
% | $161.08 Billion | Healthcare | Drug Manufacturers - General | $129.83 | -3.72% |
| 3 |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX |
% | $110.45 Billion | Healthcare | Biotechnology | $485.39 | -2.24% |
| 4 |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN |
% | $64.60 Billion | Healthcare | Biotechnology | $664.52 | -0.51% |
| 5 |
argenx NV ADR
NASDAQ:ARGX |
% | $45.97 Billion | Healthcare | Biotechnology | $787.95 | -0.66% |
| 6 |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY |
% | $39.62 Billion | Healthcare | Biotechnology | $298.76 | -4.49% |
| 7 |
Natera Inc
NASDAQ:NTRA |
% | $38.66 Billion | Healthcare | Diagnostics & Research | $269.95 | -4.22% |
| 8 |
Waters Corporation
NYSE:WAT |
% | $34.91 Billion | Healthcare | Diagnostics & Research | $376.43 | -0.19% |
| 9 |
Biogen Inc
NASDAQ:BIIB |
% | $27.74 Billion | Healthcare | Drug Manufacturers - General | $199.15 | +0.12% |
| 10 |
Mettler-Toledo International Inc
NYSE:MTD |
% | $21.79 Billion | Healthcare | Diagnostics & Research | $1296.17 | +0.63% |
| 11 |
United Therapeutics Corporation
NASDAQ:UTHR |
% | $21.42 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $547.06 | -0.98% |
| 12 |
Incyte Corporation
NASDAQ:INCY |
% | $20.04 Billion | Healthcare | Biotechnology | $116.71 | -1.53% |
| 13 |
EXACT Sciences Corporation
NASDAQ:EXAS |
% | $19.80 Billion | Healthcare | Diagnostics & Research | $1819.87 | +0.25% |
| 14 |
Moderna Inc
NASDAQ:MRNA |
% | $19.49 Billion | Healthcare | Biotechnology | $68.27 | -10.83% |
| 15 |
Illumina Inc
NASDAQ:ILMN |
% | $18.34 Billion | Healthcare | Diagnostics & Research | $190.20 | -1.84% |
| 16 |
Genmab AS
NASDAQ:GMAB |
% | $16.23 Billion | Healthcare | Biotechnology | $29.00 | -2.62% |
| 17 |
Neurocrine Biosciences Inc
NASDAQ:NBIX |
% | $13.03 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $177.11 | -1.91% |
| 18 |
Exelixis Inc
NASDAQ:EXEL |
% | $12.17 Billion | Healthcare | Biotechnology | $56.50 | -1.05% |
| 19 |
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
% | $10.93 Billion | Healthcare | Biotechnology | $59.12 | -1.42% |
| 20 |
Krystal Biotech Inc
NASDAQ:KRYS |
% | $9.22 Billion | Healthcare | Biotechnology | $365.81 | -1.46% |
| 21 |
Halozyme Therapeutics Inc
NASDAQ:HALO |
% | $8.70 Billion | Healthcare | Biotechnology | $76.20 | -3.08% |
| 22 |
Repligen Corporation
NASDAQ:RGEN |
% | $7.68 Billion | Healthcare | Medical Instruments & Supplies | $144.24 | +0.21% |
| 23 |
Alkermes Plc
NASDAQ:ALKS |
% | $7.49 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $51.94 | -3.42% |
| 24 |
Bruker Corporation
NASDAQ:BRKR |
% | $5.82 Billion | Healthcare | Medical Devices | $60.06 | -0.86% |
| 25 |
Corcept Therapeutics Incorporated
NASDAQ:CORT |
% | $5.61 Billion | Healthcare | Biotechnology | $91.88 | -1.47% |
| 26 |
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD |
% | $3.66 Billion | Healthcare | Biotechnology | $26.22 | -0.72% |
| 27 |
Veracyte Inc
NASDAQ:VCYT |
% | $2.83 Billion | Healthcare | Diagnostics & Research | $56.97 | -3.93% |
| 28 |
Sarepta Therapeutics Inc
NASDAQ:SRPT |
% | $2.00 Billion | Healthcare | Biotechnology | $18.95 | -7.65% |
| 29 |
BioNTech SE
NASDAQ:BNTX
|
% | - | Healthcare | Biotechnology | - | - |
| 30 |
BeiGene Ltd
NASDAQ:BGNE
|
% | - | Healthcare | Biotechnology | - | - |
Complete list of all companies in the BTK index ranked by market capitalization. Track index constituent performance and market values. View all indices